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ABSTRACT
Arteriovenous malformations (AVM) is a relatively rare intracranial 
abnormality. Generally, it caused by congenital abnormalities that 
recognized after the bleeding started. Spontaneous intracranial 
bleeding after AVM rupture is an emergency condition and require 
immediate treatment to reduce mortality rate. After stabilization of 
intracranial bleeding due to AVM rupture, secondary injury may occur 
hours or even days after the inciting traumatic event. The injury may 
result from impairment or local declines in cerebral blood flow (CBF) 
after brain injury. The decrease in CBF is the result of local edema, 
hemorrhage, or increased intracranial pressure (ICP). An adequate 
brain resuscitation is needed to decrease brain edema and intracranial 
pressure by achieving several targets and avoid things that can 
interfere with CBF. A recovery phase should be given to the patient 
with rupture of AVM before going to definitive therapy.
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INTRODUCTION
Arteriovenous malformations (AVMs) is an abnor-
mal tangle of blood vessels in the brain or spine and 
the most common intracranial vascular malforma-
tion, with an estimated occurrence of 1:5000-1:2000 
persons.1-3 Some AVMs have no specific symptom 
and low risk to one life, while others cause severe 
and devastating effects when ruptures occur. The 
rupture rate of AVM is between 2-4% per year.4,5 
After the initial hemorrhage, the risk of recurrent 
hemorrhage is 6% in the first year before it returns 
to baseline in the following years. The risk of serious 
morbidity or mortality after hemorrhage is 30-35%, 
and the mortality rate after the first, second, and third 
hemorrhagic events are 10, 15, and 20% respectively.6 
Patients with bleeding from the AVM should be 
stabilized in accordance with acute management 
for intracranial hemorrhage (ICH) guidelines. The 
resting phase for 2 to 6 weeks after the bleeding is 
recommended prior to definitive therapy to avoid 
hematoma.7 An adequate brain resuscitation is 
needed to avoid secondary brain injury.
We will report a case of a 35 years old man 
with spontaneous intracranial bleeding suspected 
ruptured cerebral AVM, treated by clot evacuation 
and decompression by craniotomy, followed by 
brain resuscitation in intensive care unit (ICU). 
CASE REPORT
A 35-year-old man was admitted to hospital with 
a sudden severe headache associated with nausea 
or vomiting. There is no history of hyperten-
sion and the use of anticoagulant drugs. Physical 
exam finding was marked for left hemiparesis. 
Non-contrasted head CT scan revealed an ICH in 
the right parietal, volume 56.6 cm3, urging the right 
ventricle causing midline shift to the left as far as 
0.4 cm, and the presence of brain edema.
The patient was scheduled for craniotomy for 
decompression and clot evacuation under general 
anesthesia. At the time of surgery, about 50 ml of the 
intracerebral clot was evacuated. After the proce-
dure, he was transferred to the ICU with mechan-
ical ventilation. Brain resuscitation was conducted 
in ICU to minimize cerebral edema, intracranial 
pressure (ICP), and to optimize cerebral perfusion 
pressure (CPP). 
The head was elevated by 30 degrees and 
body temperature was maintained to normal. A 
mechanical ventilator is used to control PaCO2 
from 35 to 40 mmHg, with initial setting pressure 
inspiration 16 cmH2O, FiO2 60%, PEEP 4, with 
RR 14 times per minute. Blood gas analysis results 
pH 7.42, PaCO2 35.8 mmHg, PaO2 173 mmHg, 
BEecf 1.0  mmol/L and HCO3- 23,0 mmol/L. We 
also maintain blood pressure with mean arterial 
pressure (MAP) more than 80 mmHg and systolic 
pressure about 90  mmHg to make sure cerebral 
perfusion pressure (CPP) about 50 mmHg to keep 
cerebral autoregulation intact. 
Random blood sugar also checked regularly to 
avoid hyperglycemia (>180 mg/dL). Sedation and 
analgetics were given to avoid any agitation. In 
this patient, we gave fentanyl 0.25 mcg/kgBW/h 
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for analgetic and midazolam with Richmond 
Agitation-Sedation Score (RASS) target -3. We also 
gave the patient phenytoin 100 mg intravenous 
every 8 hours for seizure prophylaxis and mannitol 
was titrated down to decrease brain edema. The 
patient was extubated at day two after surgery. He 
recovered well with no neurologic deficit and was 
discharged home on day six post-surgery. Elective 
angiography was scheduled later.
DISCUSSION
The prevalence of cerebral AVMs is estimated at 
0.01-0.5%. AVM is generally present in patients 
aged between 20 and 40 years and is more 
common in those over 30 years.4,6 Our patient is 
a 35 years old man with Secondary Intracerebral 
Hemorrhage Score more than 2, has a high prob-
ability of underlying vascular etiology suspected 
rupture of AVM.8 Patients with bleeding from 
the AVM should be stabilized in accordance with 
ICH guidelines for the acute management. The 
resting phase for 2 to 6 weeks after hemorrhage is 
recommended prior to definitive therapy to avoid 
disturbance of brain parenchymal and intracere-
bral hematoma.7
An adequate brain resuscitation is needed to 
minimize cerebral edema and intracranial pressure 
(ICP) while simultaneously optimizing cerebral 
perfusion pressure (CPP) and tissue oxygenation 
to reduce secondary ischemic injury.9 All patients 
with brain injury should have their head elevated 
30 degrees to reduce cerebral edema and augment 
venous drainage from the cranial vault.9,10
Normal body temperature should be main-
tained. In 2001, Clifton et al. reported the results of 
a large, prospective, randomized trial evaluating the 
use of hypothermia in brain injury patients. In that 
study, 392 patients were randomized within 6 hours 
of injury to hypothermia (33 °C) vs. normother-
mia, and then rewarmed after 48 hours. Mortality 
was 28% in the hypothermia group and 27% in the 
normothermia group (p=0.79). The patients in the 
hypothermia group demonstrated a great incidence 
of pneumonia as well as longer hospital length of 
stay than patients in the normothermia group. The 
authors concluded that treatment with hypother-
mia, with a body temperature reaching 33°C is not 
effective in improving outcomes in patients with 
severe brain injury.9 
Hypercapnia is a potent cerebral vasodilator and 
should be avoided in patients with cerebral edema 
and elevated ICP. Hyperventilation reduces ICP 
by causing cerebral vasoconstriction and reducing 
cerebral blood flow. A PaCO2 target of 35-40 mmHg 
is appropriate in the initial resuscitation of the 
patient with severe traumatic brain injury. In 
patients with refractory elevations in ICP, a revised 
target of 30-34 mmHg may be appropriate.9 
Hyperglycemia has been associated with 
increased brain lactate resulting in local brain tissue 
acidosis. Brain tissue acidosis worsens mitochon-
drial function in the penumbra (ischemic brain 
tissue surrounding the core injury), and increase 
the size of cerebral infarction.
Systolic hypotension leads to cerebral ischemia 
and secondary brain injury. Mean arterial pressure 
(MAP) should be maintained above 80 mmHg 
through the use of judicious isotonic intravenous 
fluids (without dextrose) until an ICP monitor is 
available. The goal should be to ensure an adequate 
CPP >60 mmHg at all times. As the brain is very 
sensitive to anoxia, this will serve to improve 
oxygen delivery and further avoid secondary brain 
injury. If the patient’s MAP cannot be maintained 
above 80 mmHg with intravenous fluid alone (or 
CPP > 60 mmHg if ICP monitoring is available), 
low-dose norepinephrine should be initiated.9-11 
Intravenous sedation and analgesia are first 
line therapy for treating intracranial hypertension. 
Patients with severe brain injury are often agitated 
and require sedation regardless of their ICP. Because 
of the brain injury, it may be impossible to determine 
whether the cause of agitation is pain or another 
reason. Analgesia is best obtained using continuous 
narcotic infusions. Fentanyl has minimal hemody-
namic effects and a short half-life (10-20 minutes) 
allowing rapid titration on and off for neurologic 
examination. Propofol is a sedative-hypnotic agent 
that has a favorable pharmacokinetic profile and 
beneficial effects on both cerebral metabolic rate 
and ICP following brain injury. It has a short half-
life (9 minutes) making it easy to titrate on and off 
for neurologic examination.9
Several studies have shown that brain injury 
patients with no history of seizure disorder or 
witnessed post-traumatic seizure activity are still 
at increased risk of developing post-traumatic 
seizures if they have one or more of the following 
risk factors: GCS <10, cortical contusion, depressed 
skull fracture, epidural hematoma, subdural hema-
toma, intracerebral hematoma, penetrating head 
wound, or seizure within 24 hours of injury. In 
these patients, seizure prophylaxis reduces the risk 
of seizures in the early period (up to 7 days after 
injury) but does not alter late seizure occurrence 
(beyond 7 days). 
Hyperosmolar therapy, using either mannitol 
or hypertonic saline, has been demonstrated to 
be beneficial in reducing both cerebral edema and 
elevated ICP. Mannitol has the additional desirable 
properties of decreasing blood viscosity, increas-
ing free radical scavenging, and inhibiting cellular 
apoptosis. Mannitol should not be administered in 
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the absence of ICP monitoring unless the patient is 
showing signs of transtentorial herniation.9,10
SUMMARY
Spontaneous intracranial bleeding after rupture of 
AVM is an emergency condition and require imme-
diate treatment. Patients with bleeding from the 
AVM should be stabilized in accordance with ICH 
guidelines for the acute management. The defin-
itive treatment is started after the stabilization of 
the ICH. An adequate brain resuscitation is needed 
in purposes to minimizing cerebral edema and 
intracranial pressure (ICP) while simultaneously 
optimizing cerebral perfusion pressure (CPP) and 
tissue oxygenation to reduce secondary ischemic 
injury.
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